Skip to main content

Table 2 Main prevalence studies conducted using the PCR method

From: Rome consensus conference - statement; human papilloma virus diseases in males

Population type (n° males examined)

Country

Prevalence of positive HPV DNA (PCR test)

Prevalence of positive HPV DNA tests (high-risk genotypes)

Population (290)

USA

30.0%;

16.6%;

Giuliano et al., 2007 [7]

Military recruits (285)

Finland

16.5%;

- -

Hippelainen et al., 1993 [8]

University students (317)

USA

32.8%;

14.5%;

Weaver et al., 2004 [9]

Students and industrial workers (114)

Mexico

36.0%;

16.7%;

Lazcano-Ponce et al., 2001 [10]

Military recruits (337)

Denmark

33.8%;

- -

Kjaier et al., 2005 [11]

Military men (1030)

Mexico

44.6%;

34.8

Lajous et al., 2005 [12]

University students (381)

South Korea

8.7%;

4.2%;

Shin et al., 2004 [13]

Subjects attending STD clinics (235)

Sweden

13.2%;

8.1%;

Wikstrom et al., 2000 [14]

Subjects attending STD clinics (198)

Denmark

44.9%;

- -

Svare et al., 2002 [15]

Subjects attending STD clinics (393)

US

28.2%;

12.0%;

Baldwin et al., 2003 [16]

Subjects attending STD clinics (85)

Netherland

28.2%;

- -

Van Doornum et al., 1994 [17]

Subjects attending STD clinics (204)

Japan

5.9%;

5.9%;

Takahashi et al., 2005 [18]

Males with female partner affected by CIN (119)

Netherland

59.0%;

55.4%;

Bleeker et al., 2002 [19]

Husbands of women recruited in case–control studies on carcinoma of the cervix (1143)

Thailand, Philippines, Brazil, Columbia, Spain

16.0%;

- -

Franceschi et al., 2002 [20]

Males with female partner affected by CIN (181)

Netherland

72.9%;

58.6%;

Bleeker et al., 2005 [21]

Males with female partner affected by CIN (77)

Finland

9.1%;

- -

Hippelainen et al., 1994 [22]

Males with female partner affected by HPV (50)

Brazil

70.0%;

- -

Nicolau et al., 2005 [23]

 

Males through 18–70 years from one of the three sampling sites (1,160)

Brazil

65.2%;

12.0%; oncogenic types only

Giuliano et al., 2008 [6]

Mexico

 

USA

  
  1. PCR Polymerase Chain Reaction, CIN Cervical Intraepithelial Neoplasia.